Silver Book Fact

Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.

Innovation in the Biopharmaceutical Pipeline: A multidimensional view. http://www.phrma.org/sites/default/files/pdf/2013innovationinthebiopharmaceuticalpipeline-analysisgroupfinal.pdf. Published 2013

Reference

Title
Innovation in the Biopharmaceutical Pipeline: A multidimensional view.
Publisher
Analysis Group
Publication Date
Published 2013
Authors
Long, G and J Works
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The overall five-year survival rate for men with prostate cancer is 99 percent—up from 43 percent in 1975.  
  • Colorectal Cancer Screening: Trends, 2003-2006  
  • Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.  
  • Because of advances in treatment, the 5-year survival rate for people with actue lymphocytic leukemia has increased from 38% in 1974-1976 to 65% in 1995-2001.  
  • The overall five-year survival rate for women with invasive breast cancer is now 89 percent.